Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection

被引:8
作者
Cao, Yifan [1 ]
Liu, Hao [2 ]
Zhang, Heng [2 ]
Lin, Chao [2 ]
Li, Ruochen [1 ]
Zhang, Weijuan [3 ]
Shen, Zhenbin [2 ]
Xu, Jiejie [1 ]
机构
[1] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200032, Peoples R China
[3] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Gastric cancer; Siglec-8; Prognosis; Biomarker; Overall survival; HEPATOCELLULAR-CARCINOMA; MAST-CELLS; EOSINOPHIL; SURVIVAL; TARGET;
D O I
10.1007/s13277-016-4859-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of sialic acid-binding Ig-like lectin (Siglec) family has been detected in many malignant tumors and correlated with patient outcomes. The present study aims to investigate the prognostic value of Siglec-8 expression and refine current risk stratification system in patients with gastric cancer. Two independent sets of patients (n = 78; n = 356, respectively) with gastric cancer from Zhongshan Hospital were enrolled into this study. The expression of Siglec-8 was detected by immunohistochemistry. Cox regression analysis was used to assess the prognostic value of Siglec-8 expression and clinical outcomes. A novel molecular prognostic stratification system combining intratumoral Siglec-8 expression with TNM stage was determined by means of receiver operating characteristic analysis. Multivariate Cox regression analysis identified that intratumoral Siglec-8 low expression was an independent prognostic factor for dismal overall survival of patients with gastric cancer. Incorporating intratumoral Siglec-8 expression into the current TNM staging system showed more accuracy for predicting prognosis of patients with gastric cancer. Our study suggested that intratumoral Siglec-8 expression was an independent prognostic factor for overall survival of patients with gastric cancer. Incorporating Siglec-8 expression level into current TNM staging system might add more comprehensive prognostic information for patients with gastric cancer and lead to a more precise risk stratification system for predicting clinical outcomes.
引用
收藏
页码:10883 / 10891
页数:9
相关论文
共 21 条
[1]  
[Anonymous], [No title captured]
[2]   Significant Association of Interleukin4 Intron 3 VNTR Polymorphism with Susceptibility to Gastric Cancer in a South Indian Population from Telangana [J].
Bhayal, Amar Chand ;
Krishnaveni, Devulapalli ;
Rao, Kondadasula Pandu Ranga ;
Kumar, Adi Rakesh ;
Jyothy, Akka ;
Nallari, Pratibha ;
Venkateshwari, Ananthapur .
PLOS ONE, 2015, 10 (09)
[3]   Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors [J].
Bochner, B. S. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (03) :317-324
[4]   Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment [J].
Bochner, BS ;
Schleimer, RF .
IMMUNOLOGICAL REVIEWS, 2001, 179 :5-15
[5]   Glycan array screening reveals a candidate ligand for Siglec-8 [J].
Bochner, BS ;
Alvarez, RA ;
Mehta, P ;
Bovin, NV ;
Blixt, O ;
White, JR ;
Schnaar, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (06) :4307-4312
[6]   Siglec-8 - A novel eosinophil-specific member of the immunoglobulin superfamily [J].
Floyd, H ;
Ni, J ;
Cornish, AL ;
Zeng, ZZ ;
Liu, D ;
Carter, KC ;
Steel, J ;
Crocker, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :861-866
[7]   MEDICAL PROGRESS - GASTRIC-CARCINOMA [J].
FUCHS, CS ;
MAYER, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :32-41
[8]   Snail is an independent prognostic predictor for progression and patient survival of gastric cancer [J].
He, Hongyong ;
Chen, Weidong ;
Wang, Xuefei ;
Wang, Cong ;
Liu, Fenglin ;
Shen, Zhenbin ;
Xu, Jiejie ;
Gu, Jianxin ;
Sun, Yihong .
CANCER SCIENCE, 2012, 103 (07) :1296-1303
[9]   CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin [J].
Herrmann, Harald ;
Cerny-Reiterer, Sabine ;
Gleixner, Karoline V. ;
Blatt, Katharina ;
Herndlhofer, Susanne ;
Rabitsch, Werner ;
Jaeger, Eva ;
Mitterbauer-Hohendanner, Gerlinde ;
Streubel, Berthold ;
Selzer, Edgar ;
Schwarzinger, Ilse ;
Sperr, Wolfgang R. ;
Valent, Peter .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (02) :219-226
[10]   Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression [J].
Hudson, Sherry A. ;
Herrmann, Harald ;
Du, Jian ;
Cox, Paul ;
Haddad, El-Bdaoui ;
Butler, Barbara ;
Crocker, Paul R. ;
Ackerman, Steven J. ;
Valent, Peter ;
Bochner, Bruce S. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (06) :1045-1053